top of page
Index change event
S&P index changes, effective 9 and 10 February 2026
Ciena moved up from the MidCap 400 to the S&P 500, and Arrowhead Pharmaceuticals moved up from the SmallCap 600 to the MidCap 400.
Announced
2026-02-04
Effective
February 8, 2026 at 4:00:00 PM
Indexes Affected
3
What happened to the prices
[ADD YOUR SUMMARY]
[ADD YOUR SECOND POINT]
Two companies moved up one index each.
Dayforce left the S&P 500 and did not join another index.
[ADD YOUR POINT]
The changes, index by index
An empty cell means the company was not in the S&P family before, or left it.
S&P 500
Company | Ticker | Source Index | Final Index | Effective Date |
|---|---|---|---|---|
Ciena | CIEN | S&P MidCap 400 | S&P 500 | 02/09/2026 |
S&P MidCap 400
Company | Ticker | Source Index | Final Index | Effective Date |
|---|---|---|---|---|
Arrowhead Pharmaceuticals | ARWR | S&P SmallCap 600 | S&P MidCap 400 | 02/09/2026 |
S&P SmallCap 600
Company | Ticker | Source Index | Final Index | Effective Date |
|---|---|---|---|---|
ADT | ADT | S&P SmallCap 600 | 02/09/2026 | |
OneSpaWorld Holdings | OSW | S&P SmallCap 600 | 02/10/2026 |
S&P 100
Company | Ticker | Source Index | Final Index | Effective Date |
|---|---|---|---|---|
Price reaction
The close price is the last price before the announcement. All percentages are measured from the open price after the announcement.
Additions
Company | Ticker | Close Price | Open Price at Announcement | % Change +5 min | % Change +30 min | % Change at 20:00 Hrs | % Highest Change by Next Day Close |
|---|---|---|---|---|---|---|---|
Ciena | CIEN | 253.50 | +2.96% | ||||
Arrowhead Pharmaceuticals | ARWR | 68.06 | +2.14% | ||||
ADT | ADT | 7.75 | +3.74% | ||||
OneSpaWorld Holdings | OSW | 20.07 | +11.51% |
Deletions
Company | Ticker | Close Price | Open Price at Announcement | % Change +5 min | % Change +30 min | % Change at 20:00 Hrs | % Highest Change by Next Day Close |
|---|---|---|---|---|---|---|---|
Dayforce | DAY | ||||||
Dynavax Technologies | DVAX |
Not a Investment Advice
This page is research about past price behaviour. It is not a recommendation to buy or sell.
bottom of page